Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6636.0000 -62.00 (-0.93%)
NSE May 28, 2025 15:31 PM
Volume: 312.7K
 

announcement
Conference/Earnings Calls Alerts
logo
Divi's Laboratories Ltd.
07 Nov 2022
6636.00
-0.93%
Results Earnings Call for Q2FY23 of Divi's Laboratories
Conference Call with Divi's Laboratories Management and Analysts on Q2FY23 Performance and Outlook. Listen to the full earnings transcript.
video
audio
 
More from Divi's Laboratories Ltd.
Recommended
Capital markets consider India as US turns volatile | Screener: Stocks with high debt and interest payments
The Baseline | 28 May 2025, 11:08PM
Market closes lower, Granules India's Q4 net profit beats Forecaster estimates by 22.6%
Trendlyne Marketwatch | 28 May 2025, 04:03PM
Custom synthesis business drives growth for Divi’s Laboratories
| 10 Mar 2022